Overview
Endometrial Effects of Lipiodol
Status:
Unknown status
Unknown status
Trial end date:
2020-01-01
2020-01-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The goal is to investigate whether endometrial flushing with Lipiodol enhances fertility. Therefore, anatomo-pathological, histochemical and transcriptional changes of the endometrium after Lipiodol bathing in a general population of healthy volunteers will be determined.Phase:
Phase 3Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Universitair Ziekenhuis BrusselTreatments:
Ethiodized Oil
Criteria
Inclusion Criteria:- Women aged ≥18 and <36 years
- Regular cycle (25-35 days)
- Signed informed consent
- Participants can be included only once in the trial
- Contraceptive: barrier method only.
Exclusion Criteria:
- known iodine allergy
- Body mass index 30 or ≤18.5
- Smoking
- Previous diagnosis of PCO (Polycystic Ovary Syndrome) (>12 antral follicles in one
ovary, Rotterdam criteria 2003)
- Previous diagnosis of endometriosis, uterine malformations or intrauterine pathologies
(submucosal fibroids, endometrial polyps, and intrauterine adhesions)
- Systemic diseases such as thyroid dysfunction
- Breast-feeding or pregnancy within the last 6 months
- Intrauterine devices (IUD)
- History of recurrent miscarriage
- Known history of infertility
- Previous uterine surgery
- Pregnancy wish during the course of the study
- Women who have been previously enrolled in the trial
- Those unable to comprehend the investigational nature of the proposed study